Two-year efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: the MOBILE study

Cooper, C.; Delmas, P. D.; Felsenberg, D.; Hughes, C.; Mairon, N.; Bonvoisin, B.; Reginster, Jean-Yves

Download

Paper published in a journal (Scientific congresses and symposiums)

Two-year efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: the MOBILE study

Cooper, C.; Delmas, P. D.; Felsenberg, D. et al.

2005 • In Annals of the Rheumatic Diseases, 64 (Suppl.III), p. 68

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/83312

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

OP0036.PDF

Publisher postprint (16.19 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

General & internal medicine
Rheumatology

Author, co-author :

Cooper, C.

Delmas, P. D.

Felsenberg, D.

Hughes, C.

Mairon, N.

Bonvoisin, B.

Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé

Language :

English

Title :

Two-year efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: the MOBILE study

Publication date :

June 2005

Event name :

Congress of the European League Against Rheumatism (EULAR 2005)

Event organizer :

European League Against Rheumatism

Event place :

Vienna, Austria

Event date :

du 8 juin 2005 au 11 juin 2005

Audience :

International

Journal title :

Annals of the Rheumatic Diseases

ISSN :

0003-4967

eISSN :

1468-2060

Publisher :

BMJ Group, London, United Kingdom

Volume :

Issue :

Suppl.III

Pages :

Peer review/Selection committee :

Peer Reviewed verified by ORBi

Available on ORBi :

since 01 February 2011

Statistics

Number of views

189 (5 by ULiège)

Number of downloads

135 (3 by ULiège)

More statistics